Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to O'Connor and Colleagues Regarding "To Stay or To Go? Debate Regarding US News and World Report Pharmacy Program Rankings".

American journal of pharmaceutical education·2025
Same author

Student-to-faculty ratios and NAPLEX pass rates.

Currents in pharmacy teaching & learning·2024
Same author

Gender Equity Perceptions Among Social and Administrative Sciences Pharmacy Faculty: An AACP-APhA Task Force Report.

American journal of pharmaceutical education·2024
Same author

Persistence to Basal Insulin: Association With Health Outcomes in a Population With Type 2 Diabetes.

Clinical diabetes : a publication of the American Diabetes Association·2024
Same author

Gender equity perceptions among social and administrative science faculty: A qualitative evaluation.

Journal of the American Pharmacists Association : JAPhA·2022
Same author

Reply: Further thoughts on the decline in positivity among graduating student pharmacists.

Journal of the American Pharmacists Association : JAPhA·2022
Same journal

Healthcare cost savings through hospital pharmacist-collaborative care in heart failure: A microsimulation study.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Assessment of comprehensive medication management incorporating a patient-completed medical and medication history form in community practice.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Characterizing how community pharmacy teams engage with social drivers of health (SDOH) during routine workflow: A report from the medication safety research network of Indiana (Rx-SafeNet).

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Geographic disparities in board-certified ambulatory care pharmacists in Appalachia.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Development of consensus criteria for problematic medications in active duty service members.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Barriers and facilitators to pharmacy-based methadone dosing and dispensing: Semi-structured interviews with pharmacists.

Journal of the American Pharmacists Association : JAPhA·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Development and testing of performance measures for pharmacy services.

Donna Pillittere-Dugan1, David P Nau, Kimberly McDonough

  • 1Performance Measurement, National Committee for Quality Assurance, Washington, DC, USA.

Journal of the American Pharmacists Association : Japha
|March 18, 2009
PubMed
Summary
This summary is machine-generated.

Pilot work by the Pharmacy Quality Alliance (PQA) tested performance metrics for pharmacy services. Key measures like high-risk drug use and medication adherence show potential for quality improvement and pay-for-performance initiatives.

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Related Experiment Videos

Last Updated: Jun 24, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Area of Science:

  • Health Services Research
  • Pharmaceutical Quality
  • Health Outcomes

Background:

  • The Pharmacy Quality Alliance (PQA) is piloting the development and testing of performance metrics for pharmacy services.
  • These metrics are intended for quality improvement, benchmarking, and pay-for-performance initiatives within health plans.

Purpose of the Study:

  • To evaluate the feasibility and potential of PQA's pilot performance measures for community pharmacies.
  • To identify measures suitable for quality improvement and pay-for-performance in diverse health plan settings.

Main Methods:

  • An observational cohort study analyzed pharmaceutical claims data from four health plans (commercial, Medicare, Medicaid) and a national drug plan.
  • Pharmacy networks varied in size, with membership ranging from approximately 3,330 to 1.7 million members.

Main Results:

  • Less than 10% of pharmacies were evaluable for most measures when requiring a minimum of 30 members per measure.
  • The measure for high-risk drugs in the elderly showed the highest number of evaluable pharmacies (6,210 out of 53,153).
  • Measures for high-risk drugs in the elderly and medication adherence demonstrated potential due to observed variation and room for improvement.

Conclusions:

  • Several tested performance measures align with the criteria of being relevant, scientifically sound, and feasible.
  • Strategies for data aggregation across health and drug plans may address challenges related to sample size limitations.
  • The findings support the use of specific pharmacy performance measures for quality initiatives.